var data={"title":"Clinical manifestations and diagnosis of nocardiosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Clinical manifestations and diagnosis of nocardiosis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/contributors\" class=\"contributor contributor_credentials\">Denis Spelman, MBBS, FRACP, FRCPA, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/contributors\" class=\"contributor contributor_credentials\">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/contributors\" class=\"contributor contributor_credentials\">Jennifer Mitty, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 27, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nocardiosis is an uncommon gram-positive bacterial infection caused by aerobic actinomycetes in the genus <em>Nocardia</em>. <em>Nocardia </em>spp have the ability to cause localized or systemic suppurative disease in humans and animals [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/1-5\" class=\"abstract_t\">1-5</a>]. Nocardiosis is typically regarded as an opportunistic infection, but approximately one-third of infected patients are immunocompetent [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/5\" class=\"abstract_t\">5</a>]. (See <a href=\"topic.htm?path=microbiology-epidemiology-and-pathogenesis-of-nocardiosis#H8\" class=\"medical medical_review\">&quot;Microbiology, epidemiology, and pathogenesis of nocardiosis&quot;, section on 'Immunocompromise'</a>.)</p><p>The major clinical manifestations and diagnosis of nocardiosis will be reviewed here. Two characteristics of nocardiosis are its ability to disseminate to virtually any organ, particularly the central nervous system, and its tendency to relapse or progress despite appropriate therapy.</p><p>The classification of nocardiosis is based upon the location and extent of disease and includes pulmonary, central nervous system, cutaneous, and disseminated disease [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/2,6\" class=\"abstract_t\">2,6</a>]. Although there are no pathognomonic signs or symptoms of nocardiosis, it should be suspected in any patient who presents with brain, soft tissue, or cutaneous lesions and a concurrent or recent pulmonary process.</p><p>The microbiology, epidemiology, pathogenesis, and treatment of <em>Nocardia</em> infection are discussed separately. (See <a href=\"topic.htm?path=microbiology-epidemiology-and-pathogenesis-of-nocardiosis\" class=\"medical medical_review\">&quot;Microbiology, epidemiology, and pathogenesis of nocardiosis&quot;</a> and <a href=\"topic.htm?path=treatment-of-nocardiosis\" class=\"medical medical_review\">&quot;Treatment of nocardiosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The risk of nocardial infection is increased in immunocompromised patients, particularly those with defects in cell-mediated immunity [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/4\" class=\"abstract_t\">4</a>]. In a literature review of over 1000 cases, 64 percent of patients with nocardiosis were immunocompromised [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/5\" class=\"abstract_t\">5</a>]. (See <a href=\"topic.htm?path=microbiology-epidemiology-and-pathogenesis-of-nocardiosis#H8\" class=\"medical medical_review\">&quot;Microbiology, epidemiology, and pathogenesis of nocardiosis&quot;, section on 'Immunocompromise'</a>.)</p><p>The causes of immunocompromise have included solid organ or hematopoietic cell transplantation, glucocorticoid therapy, HIV infection (especially if the CD4 count is &lt;100 <span class=\"nowrap\">cells/mm<sup>3</sup>),</span> malignancy (most often after recent chemotherapy or glucocorticoid therapy), and diabetes mellitus [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/5,7-11\" class=\"abstract_t\">5,7-11</a>]. Chronic lung disease and alcoholism are additional risk factors for pulmonary nocardiosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/10\" class=\"abstract_t\">10</a>].</p><p>In a matched case-control study of organ transplant recipients, independent risk factors for nocardiosis were receipt of high-dose glucocorticoids, history of cytomegalovirus disease, and high levels of calcineurin inhibitors [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/7\" class=\"abstract_t\">7</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">SITES OF INFECTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Data on the sites of nocardial infection come from multiple sources [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/5,12,13\" class=\"abstract_t\">5,12,13</a>]. In one review of 1050 cases of nocardiosis, the following sites were affected [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/5\" class=\"abstract_t\">5</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Systemic (&ge;2 sites involved) &ndash; 32 percent; among patients with systemic disease, 44 percent had central nervous system (CNS) involvement</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary (only) &ndash; 39 percent</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>CNS (only) &ndash; 9 percent</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cutaneous or lymphocutaneous &ndash; 8 percent</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Single-site extrapulmonary (eg, eyes, bone) &ndash; 12 percent</p><p/><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Pulmonary</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The lungs are the primary site of nocardial infection in more than two-thirds of cases [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/3\" class=\"abstract_t\">3</a>]. <em>Nocardia </em>spp are not normally found in the respiratory tract; as a result, isolation of <em>Nocardia</em> from the sputum is almost always indicative of infection. There are reports in which a respiratory nocardial isolate has been considered a non-pathogen (ie, colonizer), but these are very uncommon [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/14\" class=\"abstract_t\">14</a>]. Most pulmonary infections are primary, but <em>Nocardia</em> can spread to the lung from other sites, such as the skin [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/15\" class=\"abstract_t\">15</a>].</p><p>The onset of pulmonary nocardiosis may be acute, subacute, or chronic and is not distinguished by any specific signs or symptoms. Fever, night sweats, fatigue, anorexia, weight loss, dyspnea, cough, hemoptysis, and pleuritic chest pain have all been described [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/2-4,6,10,16\" class=\"abstract_t\">2-4,6,10,16</a>].</p><p>Pulmonary nocardiosis may mimic or present as an exacerbation of a known or underlying lung disease. This has been described with chronic obstructive pulmonary disease [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/17\" class=\"abstract_t\">17</a>] and pulmonary sarcoidosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/18\" class=\"abstract_t\">18</a>]. The presence of such coexisting disease may delay the diagnosis of nocardial infection. Also, if the underlying disease is treated with glucocorticoids, this therapy may predispose or increase the severity of the nocardial infection.</p><p>Although 20 percent of extrapulmonary <em>Nocardia</em> infections occur in the absence of pulmonary disease, up to 50 percent of all pulmonary cases disseminate to sites outside the lungs [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/13\" class=\"abstract_t\">13</a>], most commonly the brain [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/6\" class=\"abstract_t\">6</a>]. In addition, complications such as empyema, mediastinitis, pericarditis, and superior vena cava syndrome can occur following contiguous spread of nocardial infection from a lung, pleural, or cutaneous focus [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/19-21\" class=\"abstract_t\">19-21</a>].</p><p class=\"headingAnchor\" id=\"H219372903\"><span class=\"h3\">Imaging findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A multitude of imaging findings have been demonstrated in pulmonary nocardiosis, including single or multiple nodules, lung masses (with or without cavitation), reticulonodular infiltrates, interstitial infiltrates, lobar consolidation, subpleural plaques, and pleural effusions (<a href=\"image.htm?imageKey=ID%2F77089\" class=\"graphic graphic_diagnosticimage graphicRef77089 \">image 1</a> and <a href=\"image.htm?imageKey=ID%2F65316\" class=\"graphic graphic_diagnosticimage graphicRef65316 \">image 2</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/5,22\" class=\"abstract_t\">5,22</a>]. As a result, nocardiosis has frequently been misdiagnosed initially as tuberculosis (since upper lobe involvement is common and <em>Nocardia</em> spp are weakly acid fast), invasive fungal disease, and malignancy [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/2\" class=\"abstract_t\">2</a>]. (See <a href=\"#H16\" class=\"local\">'Pulmonary nocardiosis'</a> below.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Central nervous system</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Nocardia</em> appears to have special tropism for neural tissue [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/5,6\" class=\"abstract_t\">5,6</a>], as illustrated in the retrospective review of 1050 cases of nocardiosis cited above in which the CNS was involved in approximately 20 percent of cases overall and in 44 percent of disseminated cases [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/5\" class=\"abstract_t\">5</a>]. Isolated CNS disease has been reported, but this probably represents dissemination from a resolved or transient pulmonary or cutaneous infection (<a href=\"image.htm?imageKey=ID%2F52153\" class=\"graphic graphic_diagnosticimage graphicRef52153 \">image 3</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/2\" class=\"abstract_t\">2</a>].</p><p>The hallmark of CNS nocardiosis is formation of a parenchymal abscess that can occur in any region of the brain [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/5,23,24\" class=\"abstract_t\">5,23,24</a>]. Signs and symptoms of nocardial brain abscess are diverse and nonspecific. Patients may present with fever, headache, meningismus, seizures, <span class=\"nowrap\">and/or</span> focal neurologic deficits [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/5,25\" class=\"abstract_t\">5,25</a>]. (See <a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-brain-abscess\" class=\"medical medical_review\">&quot;Pathogenesis, clinical manifestations, and diagnosis of brain abscess&quot;</a>.)</p><p>In some patients, typically those with intact immune systems, CNS nocardiosis remains clinically silent, at times persisting for years before a diagnosis is made [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/5\" class=\"abstract_t\">5</a>]. CNS nocardiosis can present with symptoms suggesting a mass lesion without any symptoms typically associated with infection [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/26,27\" class=\"abstract_t\">26,27</a>]. In such patients, nocardial brain abscess may be erroneously diagnosed as a primary or metastatic neoplasm prior to biopsy.</p><p>Nocardial meningitis is an infrequent manifestation of CNS nocardiosis and can occur with or without an associated brain abscess [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/28\" class=\"abstract_t\">28</a>]. In a case series of 28 episodes of nocardial meningitis, the clinical presentation was consistent with subacute or chronic meningitis characterized by fever (68 percent), meningismus (64 percent), headache (55 percent), and associated brain abscess (43 percent) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/29\" class=\"abstract_t\">29</a>]. The cerebrospinal fluid typically demonstrates a neutrophilic pleocytosis, hypoglycorrhachia, and elevated protein concentration, findings that are characteristic of bacterial meningitis. (See <a href=\"topic.htm?path=cerebrospinal-fluid-physiology-and-utility-of-an-examination-in-disease-states\" class=\"medical medical_review\">&quot;Cerebrospinal fluid: Physiology and utility of an examination in disease states&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Cutaneous</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Four patterns of cutaneous disease have been observed:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Primary cutaneous</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lymphocutaneous</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cutaneous involvement from a disseminated focus</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mycetoma</p><p/><p>It may be prudent to assume that immunocompetent patients with cutaneous disease who do not have a clear history of antecedent trauma at the site of their infection, a mycetoma, or a sporotrichoid (lymphocutaneous) pattern of lesions have disseminated disease until proven otherwise.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Primary cutaneous</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When the skin is the primary site of nocardiosis, the infection results from direct inoculation of organisms into the skin, often during gardening or farming; in some cases, this occurs via puncture by a thorn or splinter [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/3,5\" class=\"abstract_t\">3,5</a>]. Inoculation can also occur via trauma, surgery, a vascular catheter, an insect bite [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/30\" class=\"abstract_t\">30</a>], or an animal scratch or bite.</p><p>Nocardiosis is an uncommon cause of skin infection and is clinically indistinguishable from lesions produced by common pyogenic bacteria such as <em>Staphylococcus aureus</em> and group A <em>Streptococcus</em>. Since most superficial skin infections are treated without a bacteriologic diagnosis, the true incidence of nocardial skin infection may be underestimated.</p><p>Manifestations of primary cutaneous nocardiosis include ulcerations, pyoderma, cellulitis, nodules, and subcutaneous abscesses [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/31,32\" class=\"abstract_t\">31,32</a>]. Cellulitis presents with pain, swelling, erythema, and warmth at the affected site, typically without associated drainage; cellulitis caused by <em>Nocardia</em> spp rarely disseminates to bone, muscles, or joints [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/1,4\" class=\"abstract_t\">1,4</a>]. The diagnosis of nocardiosis as the etiologic agent of skin lesions will be delayed if a culture is not obtained [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/33\" class=\"abstract_t\">33</a>]. (See <a href=\"topic.htm?path=cellulitis-and-skin-abscess-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Cellulitis and skin abscess: Clinical manifestations and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">Lymphocutaneous</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The lymphocutaneous form of nocardiosis occurs when a primary nocardial skin infection involves the regional lymphatics, producing a nodular lymphangitis. A clinical picture identical to the lymphocutaneous syndrome caused by <em>Sporothrix schenckii</em> develops; this type of cutaneous involvement has been termed &quot;sporotrichoid nocardiosis&quot; [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/34-37\" class=\"abstract_t\">34-37</a>]. (See <a href=\"topic.htm?path=lymphangitis#H5\" class=\"medical medical_review\">&quot;Lymphangitis&quot;, section on 'Nodular lymphangitis'</a> and <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-sporotrichosis\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of sporotrichosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h3\">Cutaneous manifestations of disseminated nocardiosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Disseminated nocardiosis presents with cutaneous skin lesions in approximately 2 percent of cases; these lesions may be the first sign of the disease (<a href=\"image.htm?imageKey=ID%2F62568\" class=\"graphic graphic_picture graphicRef62568 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/38\" class=\"abstract_t\">38</a>]. Primary and secondary skin lesions cannot be distinguished based upon their appearance.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Mycetoma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A mycetoma is a chronic cutaneous infection that can be caused by fungi (eumycetoma) or members of the Actinomycetales order of bacteria, such as <em>Nocardia</em> spp (actinomycetoma) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/6\" class=\"abstract_t\">6</a>]. <em>N. brasiliensis</em> is the most common species of <em>Nocardia</em> to cause mycetoma [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/6\" class=\"abstract_t\">6</a>].</p><p>After the organism is inoculated into the skin, most commonly on the feet, legs, or back, a pyogenic response ensues with formation of a painless nodule at the site of entry. As the nodule enlarges, a chronic inflammatory response occurs. Indurated lesions develop in an indolent fashion, with sinus tract formation exuding granules composed of clumped organisms. The enlarging granulomatous mass can remain localized or can extend, eventually involving muscle and bone. Once extension has occurred, mycetomas are frequently unresponsive to antimicrobial therapy.</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Disseminated infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Disseminated nocardiosis is defined as two noncontiguous sites of involvement that may or may not include a pulmonary focus [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/2\" class=\"abstract_t\">2</a>]. <em>Nocardia</em> can disseminate from a pulmonary or cutaneous focus to virtually any organ [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/3,39\" class=\"abstract_t\">3,39</a>]. Although dissemination is presumed to result from hematogenous spread, identifying <em>Nocardia</em> in blood cultures is uncommon due in part to their fastidious nature [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/39\" class=\"abstract_t\">39</a>]. To maximize the yield of <em>Nocardia</em>, blood cultures should be incubated for approximately four weeks. (See <a href=\"#H22\" class=\"local\">'Culture techniques and incubation'</a> below.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Bacteremia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Nocardia</em> bacteremia is a rare occurrence. The presentation and risk factors for infection are similar to those in patients who are nonbacteremic; the only unique risk factor for bacteremia is an endovascular foreign body [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/39,40\" class=\"abstract_t\">39,40</a>]. As an example, in one report, 10 of 17 cases of <em>Nocardia</em> bacteremia in cancer patients were associated with a central venous catheter [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/41\" class=\"abstract_t\">41</a>]. In a literature review of 36 cases of <em>Nocardia</em> bacteremia, approximately 30 percent had concomitant bacteremia with other pathogens, mostly gram-negative organisms [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/39\" class=\"abstract_t\">39</a>].</p><p>Methods to maximize the yield of <em>Nocardia</em> on blood cultures are discussed below. (See <a href=\"#H22\" class=\"local\">'Culture techniques and incubation'</a> below.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h3\">Other sites</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most commonly involved sites (other than pulmonary, CNS, and cutaneous) are bone, heart valves (primarily prosthetic valves), joints, and kidneys [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/5,6,42,43\" class=\"abstract_t\">5,6,42,43</a>]. In addition, numerous other sites of involvement have been reported including the sinuses, eyes, spleen, liver, adrenal glands, pancreas, thyroid gland, prostate, and testicles; <em>Nocardia</em> spp can also cause epidural abscess, postsurgical mediastinitis, implantable defibrillator pocket infection, and retroperitoneal and psoas abscesses [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/2,3,6,44-57\" class=\"abstract_t\">2,3,6,44-57</a>]. When the original focus of infection cannot be identified, the patient is presumed to have resolved pulmonary or cutaneous disease.</p><p>Primary infection can also result from inoculation of organisms into the eye, resulting in keratitis and endophthalmitis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/6,58-61\" class=\"abstract_t\">6,58-61</a>]. <em>Nocardia</em> endophthalmitis after cataract surgery is an aggressive disease with poor visual outcomes in most patients [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/59\" class=\"abstract_t\">59</a>]. (See <a href=\"topic.htm?path=bacterial-endophthalmitis\" class=\"medical medical_review\">&quot;Bacterial endophthalmitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although there are no pathognomonic signs or symptoms of nocardiosis, it should be suspected in any patient who presents with brain, soft tissue, or cutaneous lesions and a concurrent or recent pulmonary process.</p><p>Nocardiosis has a broad range of clinical presentations and can present similarly to several other infections as well as malignancy. Many patients with nocardiosis are immunocompromised, necessitating empiric therapy upon presentation while a diagnosis is sought. The differential diagnosis varies with the site of infection.</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Pulmonary nocardiosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of pulmonary nocardiosis includes the following disorders:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fungal infection (eg, <em>Aspergillus</em> spp, zygomycosis [mucormycosis], <em>Cryptococcus neoformans</em>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mycobacterial infection (eg, <em>M. tuberculosis</em>, <em>M. avium </em>intracellulare complex, <em>M. kansasii</em>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bacterial infection (eg, <em>Rhodococcus equi</em> and gram-negative bacilli such as <em>Pseudomonas aeruginosa</em> and <em>Klebsiella pneumoniae</em>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malignancy (eg, primary lung cancer, lung metastases)</p><p/><p>(See <a href=\"topic.htm?path=approach-to-the-immunocompromised-patient-with-fever-and-pulmonary-infiltrates\" class=\"medical medical_review\">&quot;Approach to the immunocompromised patient with fever and pulmonary infiltrates&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">CNS nocardiosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of central nervous system (CNS) nocardiosis includes the following disorders:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other causes of bacterial brain abscess, including anaerobic bacteria</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fungal infection (eg, <em>Aspergillus</em> spp, <em>Cryptococcus neoformans</em>, <em>Coccidioides immitis</em>, zygomycosis [mucormycosis])</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Parasitic infection (eg, toxoplasmosis, cysticercosis)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malignancy (eg, primary CNS lymphoma, CNS metastases)</p><p/><p>(See <a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-brain-abscess\" class=\"medical medical_review\">&quot;Pathogenesis, clinical manifestations, and diagnosis of brain abscess&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H683292219\"><span class=\"h2\">Cutaneous nocardiosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of cutaneous nocardiosis includes the following disorders:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fungal infection (eg, <em>Aspergillus</em> spp, <em>Cryptococcus</em> spp, <em>Scedosporium apiospermum</em><span class=\"nowrap\">/<em>Pseudallescheria</span> boydii</em>, <em>Sporothrix schenckii</em>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nontuberculous mycobacterial infection (particularly the rapidly growing nontuberculous mycobacteria, <em>Mycobacterium chelonae</em> and <em>M. fortuitum</em>, and the intermediately growing mycobacterium <em>M. marinum</em>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bacterial infection (eg, <em>Erysipelothrix rhusiopathiae</em> and <em>Francisella tularensis</em>, which causes tularemia)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Parasitic infection (eg, cutaneous leishmaniasis)</p><p/><p>(See <a href=\"topic.htm?path=fever-and-rash-in-immunocompromised-patients-without-hiv-infection\" class=\"medical medical_review\">&quot;Fever and rash in immunocompromised patients without HIV infection&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A definitive diagnosis of nocardiosis requires the isolation and identification of the organism from a clinical specimen. Delay in establishing the correct diagnosis is common due to the nonspecific and diverse clinical presentation of nocardiosis and the inherent difficulty in cultivating <em>Nocardia</em>. The mean time from the development of symptoms to diagnosis has, in different studies, ranged from 42 days to 12 months [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/10,62\" class=\"abstract_t\">10,62</a>].</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Appropriate specimens</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The difficulty in establishing a diagnosis of nocardiosis may be related to the inadequacy of specimens obtained by noninvasive means. In one case series, 44 percent of pulmonary infections required an invasive procedure to establish the diagnosis of nocardiosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/62\" class=\"abstract_t\">62</a>]. When an invasive procedure is performed, cultures are positive in 85 to 90 percent of specimens [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/63\" class=\"abstract_t\">63</a>].</p><p>Even when adequate specimens are obtained, recovery of <em>Nocardia</em> in the laboratory can be difficult. Thus, when <em>Nocardia</em> infection is suspected, the clinical laboratory should be notified so that specific media and staining procedures can be performed on submitted samples. Certain sputum decontamination solutions have been shown to be toxic to <em>Nocardia</em> spp, particularly sodium hydroxide, N-acetylcysteine, and benzalkonium chloride [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/2,6\" class=\"abstract_t\">2,6</a>]. These solutions should be avoided when isolation of <em>Nocardia</em> is attempted. Examination of clinical specimens for <em>Nocardia</em> should include macroscopic examination for granules, which, when found, can be crushed for microscopic examination [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/1\" class=\"abstract_t\">1</a>].</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Gram stain</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Nocardia</em> spp appear as delicate, filamentous, sometimes beaded [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/1\" class=\"abstract_t\">1</a>], branching gram-positive rods in clinical specimens (<a href=\"image.htm?imageKey=ID%2F80426\" class=\"graphic graphic_picture graphicRef80426 \">picture 2</a>).</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Modified acid-fast staining</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the proper clinical setting, a presumptive diagnosis of nocardiosis can be made if partially acid-fast filamentous branching rods are visualized in clinical specimens. The value of direct examination of specimens cannot be overemphasized, since early diagnosis and treatment of nocardiosis have been associated with improved clinical outcomes in some patient groups [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/16,64\" class=\"abstract_t\">16,64</a>].</p><p>The acid-fast nature of <em>Nocardia</em> is most reliably demonstrated when organisms are stained with the modified acid-fast (Kinyoun) stain (<a href=\"image.htm?imageKey=ID%2F66920\" class=\"graphic graphic_picture graphicRef66920 \">picture 3</a>) or the auramine-rhodamine fluorescent stain. The Kinyoun method substitutes 1% sulfuric acid for acid alcohol as a decolorizer, which allows the less tenaciously acid-fast <em>Nocardia</em> to retain fuchsin [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/6\" class=\"abstract_t\">6</a>]. The acid-fast staining property of <em>Nocardia</em> is often lost in older cultures.</p><p>The acid-fast reaction and the aerial branching of mycelial-like structures extending from the agar surface are simple tests that differentiate <em>Nocardia</em> from other aerobic and anaerobic actinomyces. (See <a href=\"topic.htm?path=microbiology-epidemiology-and-pathogenesis-of-nocardiosis\" class=\"medical medical_review\">&quot;Microbiology, epidemiology, and pathogenesis of nocardiosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Culture techniques and incubation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most routine aerobic bacterial, fungal, and mycobacterial culture media can support <em>Nocardia</em>. However, selective media, such as buffered charcoal yeast extract (the media used for the isolation of <em>Legionella</em> spp) and modified Thayer-Martin agar may be beneficial in decreasing the overgrowth of other organisms in specimens derived from nonsterile sites [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/2,6\" class=\"abstract_t\">2,6</a>]. <em>Nocardia</em> can also be cultured on <em>Mycobacterium</em> culture media, such as Lowenstein-Jensen (LJ) media [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/65\" class=\"abstract_t\">65</a>]. In our experience, approximately 20 percent of <em>Nocardia</em> are isolated on such media.</p><p>In routine aerobic cultures, <em>Nocardia</em> spp have variable colonial morphology, from chalky white to pigment-producing orange, yellow, or brown colonies [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/1\" class=\"abstract_t\">1</a>], and usually require 5 to 21 days for growth [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/3,5,66\" class=\"abstract_t\">3,5,66</a>]. To maximize the yield of <em>Nocardia</em>, blood cultures should be incubated for approximately four weeks. Since most routine fluid or tissue cultures are discarded at 48 to 72 hours, laboratory personnel must be notified when nocardiosis is suspected in order to ensure an adequate incubation period.</p><p>Although <em>Nocardia</em> spp can be recovered in most blood culture systems, this rarely occurs despite frequent hematogenous dissemination [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/39\" class=\"abstract_t\">39</a>]. Most cases of bacteremia are associated with endovascular devices, such as central venous catheters [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/39-41\" class=\"abstract_t\">39-41</a>]. Thus, blood cultures should be considered for patients with endovascular devices who remain febrile despite appropriate therapy or have evidence of embolic disease. Blood cultures should be held for up to two to four weeks, with blind subculture to selective media [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/66\" class=\"abstract_t\">66</a>]. Communication by the clinician with the laboratory is essential to maximize the yield of <em>Nocardia</em> from blood cultures. (See <a href=\"#H12\" class=\"local\">'Bacteremia'</a> above.)</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h2\">Speciation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Methods of speciation have undergone improvement. It is now clear that, with previously used biochemical techniques for <em>Nocardia </em>speciation, misidentification was common and that molecular methods, such as 16S ribosomal RNA (rRNA) gene analysis, are more accurate [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/67\" class=\"abstract_t\">67</a>]. 16S rRNA gene analysis and other molecular techniques, such as restriction fragment length polymorphisms and multilocus sequence analysis, are therefore the preferred methods for speciation [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/12,13,68-73\" class=\"abstract_t\">12,13,68-73</a>]. (See <a href=\"topic.htm?path=microbiology-epidemiology-and-pathogenesis-of-nocardiosis#H3\" class=\"medical medical_review\">&quot;Microbiology, epidemiology, and pathogenesis of nocardiosis&quot;, section on 'Taxonomy'</a>.)</p><p>The sensitivity and specificity of a 16S rRNA-based polymerase chain reaction (PCR) assay was examined using 18 samples (eg, skin biopsies, abscess material, sputum, and bronchoalveolar lavage fluid) from patients with nocardiosis diagnosed by conventional cultures and 20 clinical samples from patients with confirmed tuberculosis as negative controls [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/74\" class=\"abstract_t\">74</a>]. All specimens from patients with nocardiosis were positive, whereas none of the 20 control samples were positive, confirming the sensitivity and specificity of the primers and PCR protocol. Sequencing allowed identification to the species level.</p><p>There are increasing reports of <em>Nocardia</em> identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF) technology [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/75-79\" class=\"abstract_t\">75-79</a>]. However, success rates are variable and may depend on modification of the standard extraction method and expansion of the currently available databases [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/76\" class=\"abstract_t\">76</a>]. This may be improved with future expansion of the MALDI-TOF databases <span class=\"nowrap\">and/or</span> modification of the bacterial processing methods.</p><p class=\"headingAnchor\" id=\"H19082898\"><span class=\"h2\">Histopathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Histopathology of tissue specimens most often shows necrosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/80-82\" class=\"abstract_t\">80-82</a>] with abscess (including microabscess) formation. There may be a mixed cellular infiltrate of polymorphonuclear leucocytes [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/81,83\" class=\"abstract_t\">81,83</a>], lymphocytes [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/81,83\" class=\"abstract_t\">81,83</a>], plasma cells [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/83,84\" class=\"abstract_t\">83,84</a>], and hemosiderin-laden macrophages [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/83,84\" class=\"abstract_t\">83,84</a>]. Granulomas with central necrosis mimicking tuberculosis have been described in lung and pleural tissue [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/81,85\" class=\"abstract_t\">81,85</a>], but these findings occur infrequently [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/83\" class=\"abstract_t\">83</a>]. Organisms can sometimes be seen on histologic stains, including methenamine silver and the Grocott stain [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/80,82,85\" class=\"abstract_t\">80,82,85</a>].</p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h2\">Susceptibility testing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In vitro susceptibility studies have shown that different <em>Nocardia </em>species and strains often have markedly different susceptibility patterns, underlining the importance of obtaining speciation and susceptibility testing of all clinical isolates [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/2,4,66,86-90\" class=\"abstract_t\">2,4,66,86-90</a>]. This is particularly important because most patients with nocardiosis are immunocompromised, the central nervous system (CNS) is frequently involved, and there is a high mortality rate of untreated or inadequately treated infection. As an example, identification of <em>N. farcinica</em> is important because this species characteristically demonstrates resistance to third-generation cephalosporins and is often resistant to <a href=\"topic.htm?path=imipenem-and-cilastatin-drug-information\" class=\"drug drug_general\">imipenem</a> [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/4,66\" class=\"abstract_t\">4,66</a>]. Furthermore, <a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">trimethoprim-sulfamethoxazole</a> (TMP-SMX) intolerance is common, which can necessitate switching to alternative agents. Antibiotic susceptibility patterns in the different <em>Nocardia</em> spp are discussed separately. (See <a href=\"topic.htm?path=treatment-of-nocardiosis#H2\" class=\"medical medical_review\">&quot;Treatment of nocardiosis&quot;, section on 'Antibiotic susceptibility'</a>.)</p><p>The optimal method for antimicrobial susceptibility testing, as recommended by the Clinical and Laboratory Standards Institute (CLSI, formerly the National Committee for Clinical Laboratory Standards [NCCLS]) is the microdilution method [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/91\" class=\"abstract_t\">91</a>]. As recommended by CLSI, the following drugs are tested by microdilution: <a href=\"topic.htm?path=amikacin-drug-information\" class=\"drug drug_general\">amikacin</a>, <a href=\"topic.htm?path=amoxicillin-and-clavulanate-drug-information\" class=\"drug drug_general\">amoxicillin-clavulanate</a>, <a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">ceftriaxone</a>, <a href=\"topic.htm?path=ciprofloxacin-drug-information\" class=\"drug drug_general\">ciprofloxacin</a>, <a href=\"topic.htm?path=clarithromycin-drug-information\" class=\"drug drug_general\">clarithromycin</a>, <a href=\"topic.htm?path=imipenem-and-cilastatin-drug-information\" class=\"drug drug_general\">imipenem</a>, <a href=\"topic.htm?path=linezolid-drug-information\" class=\"drug drug_general\">linezolid</a>, <a href=\"topic.htm?path=minocycline-drug-information\" class=\"drug drug_general\">minocycline</a> (which also predicts <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> susceptibility), sulfamethoxazole or <a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">trimethoprim-sulfamethoxazole</a>, and <a href=\"topic.htm?path=tobramycin-drug-information\" class=\"drug drug_general\">tobramycin</a> [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/91\" class=\"abstract_t\">91</a>].The E-test method of susceptibility testing has been considered by some experts to be an appropriate alternative method for susceptibility testing of <em>Nocardia</em> [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/1,12,92,93\" class=\"abstract_t\">1,12,92,93</a>].</p><p>Despite the availability of this technique in hospital laboratories, the minimum inhibitory concentration (MIC) of antimicrobials can be difficult to interpret. Isolates of <em>Nocardia</em> may therefore be sent to a reference laboratory for precise identification and confirmation of susceptibility testing [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/2\" class=\"abstract_t\">2</a>].</p><p>Reference laboratories that perform <em>Nocardia</em> spp culture and susceptibility testing include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.mayomedicallaboratories.com/&amp;token=XsuOnnm5zlcDDa3AH9M57v0B+li3irzSGF5xIZzr3Ni18/MbXPqa9+qr24WNQOAi&amp;TOPIC_ID=5515\" target=\"_blank\" class=\"external\">Mayo Medical Laboratories</a></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The <span class=\"nowrap\">Mycobacteria/Nocardia</span> Research Laboratory, <a href=\"http://www.uthealth.org/&amp;token=cn335En+yh5fmtBMWc3TlLfmdd9szol435lcZkQR+CSvALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=5515\" target=\"_blank\" class=\"external\">The University of Texas Health Science Center</a></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.uphs.upenn.edu/&amp;token=Ky3pSh/6mthcqZl12qeDU4CsSGoD1CXSuhHe9P0vxwKvALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=5515\" target=\"_blank\" class=\"external\">The University of Pennsylvania Health System</a></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.aruplab.com/&amp;token=oMC3X1+WCiEAM8+ZRgy2kBv+lu1b4mGHAzkgogRqEqM=&amp;TOPIC_ID=5515\" target=\"_blank\" class=\"external\">ARUP Laboratories</a>, University of Utah</p><p/><p class=\"headingAnchor\" id=\"H26\"><span class=\"h2\">Imaging studies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Nocardia</em> spp have a propensity to cause brain infection. Thus, the presence of any symptoms indicative of CNS disease warrants brain imaging (computed tomography or magnetic resonance imaging) to exclude the presence of a brain abscess (<a href=\"image.htm?imageKey=ID%2F78604\" class=\"graphic graphic_diagnosticimage graphicRef78604 \">image 4</a>). In addition, all immunocompromised patients with cutaneous <span class=\"nowrap\">and/or</span> pulmonary nocardiosis, even those without symptoms of CNS involvement, should undergo brain imaging. Immunocompetent patients with pulmonary nocardiosis should also undergo radiographic evaluation to exclude CNS infection. Immunocompetent patients with primary cutaneous nocardiosis only rarely have disseminated disease, and the decision regarding brain imaging should be made on an individual basis.</p><p class=\"headingAnchor\" id=\"H27\"><span class=\"h1\">SUMMARY</span></p><p class=\"headingAnchor\" id=\"H28\"><span class=\"h2\">Clinical manifestations</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nocardiosis is caused by an aerobic actinomycete in the genus <em>Nocardia</em>, an unusual gram-positive bacteria. Nocardial infection most often occurs in immunocompromised patients. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The most common disease sites are the lung, central nervous system (CNS), and skin. There are no pathognomonic signs or symptoms for nocardiosis. It should be suspected in any patient who presents with brain, soft tissue, or cutaneous lesions and a concurrent or recent pulmonary process. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The lungs are the primary site of nocardial infection in more than two-thirds of cases. The onset of pulmonary nocardiosis may be acute, subacute, or chronic and is not distinguished by any specific signs or symptoms. (See <a href=\"#H4\" class=\"local\">'Pulmonary'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Radiographic findings of lung involvement are variable and include single or multiple nodules, lung masses (with or without cavitation), reticulonodular infiltrates, interstitial infiltrates, lobar consolidation, subpleural plaques, and pleural effusions (<a href=\"image.htm?imageKey=ID%2F77089\" class=\"graphic graphic_diagnosticimage graphicRef77089 \">image 1</a> and <a href=\"image.htm?imageKey=ID%2F65316\" class=\"graphic graphic_diagnosticimage graphicRef65316 \">image 2</a>). (See <a href=\"#H4\" class=\"local\">'Pulmonary'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>CNS disease accounts for approximately 20 percent of <em>Nocardia</em> cases and most commonly results from dissemination of infection from a pulmonary or cutaneous site. The hallmark of CNS nocardiosis is formation of a parenchymal abscess that can occur in any region of the brain. (See <a href=\"#H5\" class=\"local\">'Central nervous system'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Four patterns of cutaneous disease occur: primary cutaneous, lymphocutaneous, cutaneous involvement from a disseminated focus, and mycetoma. (See <a href=\"#H6\" class=\"local\">'Cutaneous'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most cutaneous disease results from the direct inoculation of organisms into the skin from trauma. (See <a href=\"#H7\" class=\"local\">'Primary cutaneous'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Disseminated nocardiosis is defined as two or more noncontiguous sites of involvement that may or may not include a pulmonary focus. (See <a href=\"#H11\" class=\"local\">'Disseminated infection'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H29\"><span class=\"h2\">Diagnosis</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A definitive diagnosis of nocardiosis requires the isolation and identification of the organism from a clinical specimen. (See <a href=\"#H18\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Establishing a diagnosis of nocardiosis is problematic since an invasive procedure is often required to obtain an adequate specimen and recovery of <em>Nocardia</em> in the laboratory is difficult because of its slow growth. (See <a href=\"#H19\" class=\"local\">'Appropriate specimens'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the proper clinical setting, a presumptive diagnosis of nocardiosis can be made if partially acid-fast filamentous branching rods are visualized in clinical specimens. (See <a href=\"#H21\" class=\"local\">'Modified acid-fast staining'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Nocardia</em> in routine aerobic cultures usually require 5 to 21 days for growth. (See <a href=\"#H22\" class=\"local\">'Culture techniques and incubation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Precise speciation and susceptibility testing of clinical isolates is important because resistance patterns vary by species. (See <a href=\"#H23\" class=\"local\">'Speciation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Polymerase chain reaction provides more accurate and rapid results for the diagnosis of nocardiosis than the conventional methods but is not available in most clinical laboratories. (See <a href=\"#H23\" class=\"local\">'Speciation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Nocardia</em> isolates are usually sent to a reference laboratory for precise identification and susceptibility testing. (See <a href=\"#H25\" class=\"local\">'Susceptibility testing'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Because of the propensity for <em>Nocardia</em> spp to cause central nervous system infection, brain imaging should be performed in all immunocompromised patients and in all patients with pulmonary nocardiosis. (See <a href=\"#H26\" class=\"local\">'Imaging studies'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/1\" class=\"nounderline abstract_t\">Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ Jr. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev 2006; 19:259.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/2\" class=\"nounderline abstract_t\">Lerner PI. Nocardiosis. Clin Infect Dis 1996; 22:891.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/3\" class=\"nounderline abstract_t\">Lederman ER, Crum NF. A case series and focused review of nocardiosis: clinical and microbiologic aspects. Medicine (Baltimore) 2004; 83:300.</a></li><li class=\"breakAll\">Sorrel TC, Mitchell DH, Iredell JR, Chen SC-A. Nocardia Species. In: Principles and Practice of Infectious Diseases, 7th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone Elsevier, Philadelphia 2010. p.3199.</li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/5\" class=\"nounderline abstract_t\">Beaman BL, Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev 1994; 7:213.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/6\" class=\"nounderline abstract_t\">McNeil MM, Brown JM. The medically important aerobic actinomycetes: epidemiology and microbiology. Clin Microbiol Rev 1994; 7:357.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/7\" class=\"nounderline abstract_t\">Peleg AY, Husain S, Qureshi ZA, et al. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis 2007; 44:1307.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/8\" class=\"nounderline abstract_t\">Saubolle MA, Sussland D. Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol 2003; 41:4497.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/9\" class=\"nounderline abstract_t\">Castro JG, Espinoza L. Nocardia species infections in a large county hospital in Miami: 6 years experience. J Infect 2007; 54:358.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/10\" class=\"nounderline abstract_t\">Mart&iacute;nez Tom&aacute;s R, Men&eacute;ndez Villanueva R, Reyes Calzada S, et al. Pulmonary nocardiosis: risk factors and outcomes. Respirology 2007; 12:394.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/11\" class=\"nounderline abstract_t\">Anagnostou T, Arvanitis M, Kourkoumpetis TK, et al. Nocardiosis of the central nervous system: experience from a general hospital and review of 84 cases from the literature. Medicine (Baltimore) 2014; 93:19.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/12\" class=\"nounderline abstract_t\">Valdezate S, Garrido N, Carrasco G, et al. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain. J Antimicrob Chemother 2017; 72:754.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/13\" class=\"nounderline abstract_t\">Coussement J, Lebeaux D, van Delden C, et al. Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study. Clin Infect Dis 2016; 63:338.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/14\" class=\"nounderline abstract_t\">Hardak E, Yigla M, Berger G, et al. Clinical spectrum and outcome of Nocardia infection: experience of 15-year period from a single tertiary medical center. Am J Med Sci 2012; 343:286.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/15\" class=\"nounderline abstract_t\">Kahn FW, Gornick CC, Tofte RW. Primary cutaneous Nocardia asteroides infection with dissemination. Am J Med 1981; 70:859.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/16\" class=\"nounderline abstract_t\">Uttamchandani RB, Daikos GL, Reyes RR, et al. Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome. Clin Infect Dis 1994; 18:348.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/17\" class=\"nounderline abstract_t\">Khare V, Gupta P, Himanshu D, Kumar D. Emergence of co-trimoxazole resistant Nocardia brasiliensis causing fatal pneumonia. BMJ Case Rep 2013; 2013.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/18\" class=\"nounderline abstract_t\">Zuk J, Bazan-Socha S, Zarychta J, et al. Disseminated nocardiosis mimicking exacerbation of pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2013; 30:65.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/19\" class=\"nounderline abstract_t\">Poland GA, Jorgensen CR, Sarosi GA. Nocardia asteroides pericarditis: report of a case and review of the literature. Mayo Clin Proc 1990; 65:819.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/20\" class=\"nounderline abstract_t\">Kessler R, Follis F, Daube D, Wernly J. Constrictive pericarditis from Nocardia asteroides infection. Ann Thorac Surg 1991; 52:861.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/21\" class=\"nounderline abstract_t\">Abdelkafi S, Dubail D, Bosschaerts T, et al. Superior vena cava syndrome associated with Nocardia farcinica infection. Thorax 1997; 52:492.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/22\" class=\"nounderline abstract_t\">Hwang JH, Koh WJ, Suh GY, et al. Pulmonary nocardiosis with multiple cavitary nodules in a HIV-negative immunocompromised patient. Intern Med 2004; 43:852.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/23\" class=\"nounderline abstract_t\">Sabuncuo&#287;lu H, Cibali A&ccedil;ikgo Z Z, Caydere M, et al. Nocardia farcinica brain abscess: a case report and review of the literature. Neurocirugia (Astur) 2004; 15:600.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/24\" class=\"nounderline abstract_t\">Yildiz O, Alp E, Tokgoz B, et al. Nocardiosis in a teaching hospital in the Central Anatolia region of Turkey: treatment and outcome. Clin Microbiol Infect 2005; 11:495.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/25\" class=\"nounderline abstract_t\">Mamelak AN, Obana WG, Flaherty JF, Rosenblum ML. Nocardial brain abscess: treatment strategies and factors influencing outcome. Neurosurgery 1994; 35:622.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/26\" class=\"nounderline abstract_t\">Menk&uuml; A, Kurtsoy A, Tucer B, et al. Nocardia brain abscess mimicking brain tumour in immunocompetent patients: report of two cases and review of the literature. Acta Neurochir (Wien) 2004; 146:411.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/27\" class=\"nounderline abstract_t\">Yamada SM, Nakai E, Toyonaga S, et al. A rapidly enlarging nocardial brain abscess mimicking malignant glioma. J Nippon Med Sch 2005; 72:308.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/28\" class=\"nounderline abstract_t\">Chow E, Moore T, Deville J, Nielsen K. Nocardia asteroides brain abscesses and meningitis in an immunocompromized 10-year-old child. Scand J Infect Dis 2005; 37:511.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/29\" class=\"nounderline abstract_t\">Bross JE, Gordon G. Nocardial meningitis: case reports and review. Rev Infect Dis 1991; 13:160.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/30\" class=\"nounderline abstract_t\">Paredes BE, Hunger RE, Braathen LR, Brand CU. Cutaneous nocardiosis caused by Nocardia brasiliensis after an insect bite. Dermatology 1999; 198:159.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/31\" class=\"nounderline abstract_t\">Satterwhite TK, Wallace RJ Jr. Primary cutaneous nocardiosis. JAMA 1979; 242:333.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/32\" class=\"nounderline abstract_t\">Shimizu T, Furumoto H, Asagami C, et al. Disseminated subcutaneous Nocardia farcinica abscesses in a nephrotic syndrome patient. J Am Acad Dermatol 1998; 38:874.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/33\" class=\"nounderline abstract_t\">Kil EH, Tsai CL, Kwark EH, Goldwasser J. A case of nocardiosis with an uncharacteristically long incubation period. Cutis 2005; 76:33.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/34\" class=\"nounderline abstract_t\">Smego RA Jr, Gallis HA. The clinical spectrum of Nocardia brasiliensis infection in the United States. Rev Infect Dis 1984; 6:164.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/35\" class=\"nounderline abstract_t\">Tsuboi R, Takamori K, Ogawa H, et al. Lymphocutaneous nocardiosis caused by Nocardia asteroides. Case report and literature review. Arch Dermatol 1986; 122:1183.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/36\" class=\"nounderline abstract_t\">Smego RA Jr, Castiglia M, Asperilla MO. Lymphocutaneous syndrome. A review of non-sporothrix causes. Medicine (Baltimore) 1999; 78:38.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/37\" class=\"nounderline abstract_t\">Inamadar AC, Palit A, Peerapur BV, Rao SD. Sporotrichoid nocardiosis caused by Nocardia nova in a patient infected with human immunodeficiency virus. Int J Dermatol 2004; 43:824.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/38\" class=\"nounderline abstract_t\">Threlkeld SC, Hooper DC. Update on management of patients with Nocardia infection. Curr Clin Top Infect Dis 1997; 17:1.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/39\" class=\"nounderline abstract_t\">Kontoyiannis DP, Ruoff K, Hooper DC. Nocardia bacteremia. Report of 4 cases and review of the literature. Medicine (Baltimore) 1998; 77:255.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/40\" class=\"nounderline abstract_t\">Matulionyte R, Rohner P, U&ccedil;kay I, et al. Secular trends of nocardia infection over 15 years in a tertiary care hospital. J Clin Pathol 2004; 57:807.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/41\" class=\"nounderline abstract_t\">Al Akhrass F, Hachem R, Mohamed JA, et al. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis 2011; 17:1651.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/42\" class=\"nounderline abstract_t\">Kahraman S, Genctoy G, Arici M, et al. Septic arthritis caused by Nocardia asteroides in a renal transplant recipient. Transplant Proc 2004; 36:1415.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/43\" class=\"nounderline abstract_t\">Subha ST, Raman R. Nocardia infection of the mastoid in an immunocompromised patient. Med J Malaysia 2004; 59:688.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/44\" class=\"nounderline abstract_t\">Wenger PN, Brown JM, McNeil MM, Jarvis WR. Nocardia farcinica sternotomy site infections in patients following open heart surgery. J Infect Dis 1998; 178:1539.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/45\" class=\"nounderline abstract_t\">Lalitha P, Tiwari M, Prajna NV, et al. Nocardia keratitis: species, drug sensitivities, and clinical correlation. Cornea 2007; 26:255.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/46\" class=\"nounderline abstract_t\">Yin X, Liang S, Sun X, et al. Ocular nocardiosis: HSP65 gene sequencing for species identification of Nocardia spp. Am J Ophthalmol 2007; 144:570.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/47\" class=\"nounderline abstract_t\">Roberts SA, Bartley J, Braatvedt G, Ellis-Pegler RB. Nocardia asteroides as a cause of sphenoidal sinusitis: case report. Clin Infect Dis 1995; 21:1041.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/48\" class=\"nounderline abstract_t\">Arabi Y, Fairfax MR, Szuba MJ, et al. Adrenal insufficiency, recurrent bacteremia, and disseminated abscesses caused by Nocardia asteroides in a patient with acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis 1996; 24:47.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/49\" class=\"nounderline abstract_t\">Carriere C, Marchandin H, Andrieu JM, et al. Nocardia thyroiditis: unusual location of infection. J Clin Microbiol 1999; 37:2323.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/50\" class=\"nounderline abstract_t\">P&oacute;lay A, Pep&oacute; J, Zsolt J, Kov&aacute;cs G. [Nocardia infections following heart operations]. Dermatol Monatsschr 1973; 159:429.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/51\" class=\"nounderline abstract_t\">Atalay B, Azap O, Cekinmez M, et al. Nocardial epidural abscess of the thoracic spinal cord and review of the literature. J Infect Chemother 2005; 11:169.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/52\" class=\"nounderline abstract_t\">Routh JC, Lischer GH, Leibovich BC. Epididymo-orchitis and testicular abscess due to Nocardia asteroides complex. Urology 2005; 65:591.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/53\" class=\"nounderline abstract_t\">Verghese S, Kurian VM, Maria CF, et al. Nocardia asteroides mediastinitis complicating coronary artery bypass surgery. J Assoc Physicians India 2003; 51:1009.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/54\" class=\"nounderline abstract_t\">Boell K, Gotoff R, Foltzer M, et al. Implantable defibrillator pocket infection and bacteremia caused by Nocardia nova complex isolate. J Clin Microbiol 2003; 41:5325.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/55\" class=\"nounderline abstract_t\">O'Rourke S, Kapoor S, Carter-Adkins D, Pachulski RT. ICD nocardiosis. J Interv Cardiol 2003; 16:375.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/56\" class=\"nounderline abstract_t\">Qu L, Strollo DC, Bond G, Kusne S. Nocardia prostatitis in a small intestine transplant recipient. Transpl Infect Dis 2003; 5:94.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/57\" class=\"nounderline abstract_t\">Smit LH, Leemans R, Overbeek BP. Nocardia farcinica as the causative agent in a primary psoas abscess in a previously healthy cattle inspector. Clin Microbiol Infect 2003; 9:445.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/58\" class=\"nounderline abstract_t\">Chaidaroon W, Tantayakom T. Nocardia keratitis in a human immunodeficiency virus patient. Jpn J Ophthalmol 2004; 48:272.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/59\" class=\"nounderline abstract_t\">Eggink CA, Wesseling P, Boiron P, Meis JF. Severe keratitis due to Nocardia farcinica. J Clin Microbiol 1997; 35:999.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/60\" class=\"nounderline abstract_t\">Haripriya A, Lalitha P, Mathen M, et al. Nocardia endophthalmitis after cataract surgery: clinicomicrobiological study. Am J Ophthalmol 2005; 139:837.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/61\" class=\"nounderline abstract_t\">Hudson JD, Danis RP, Chaluvadi U, Allen SD. Posttraumatic exogenous Nocardia endophthalmitis. Am J Ophthalmol 2003; 135:915.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/62\" class=\"nounderline abstract_t\">Georghiou PR, Blacklock ZM. Infection with Nocardia species in Queensland. A review of 102 clinical isolates. Med J Aust 1992; 156:692.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/63\" class=\"nounderline abstract_t\">Palmer DL, Harvey RL, Wheeler JK. Diagnostic and therapeutic considerations in Nocardia asteroides infection. Medicine (Baltimore) 1974; 53:391.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/64\" class=\"nounderline abstract_t\">Simpson GL, Stinson EB, Egger MJ, Remington JS. Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis 1981; 3:492.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/65\" class=\"nounderline abstract_t\">Muricy EC, Lemes RA, Bombarda S, et al. Differentiation between Nocardia spp. and Mycobacterium spp.: Critical aspects for bacteriological diagnosis. Rev Inst Med Trop Sao Paulo 2014; 56:397.</a></li><li class=\"breakAll\">Conville PS, Witebsky FG. Nocardia, Rhodococcus, Gordonia, Actinomadura, Streptomyces, and other Aerobic Actinomycetes. In: Manual of Clinical Microbiology, 9th Ed, Murray PR, Baron EJ, Jorgensen JH, et al (Eds), ASM Press, Washington, DC 2007. p.515.</li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/67\" class=\"nounderline abstract_t\">Liu WL, Lai CC, Ko WC, et al. Clinical and microbiological characteristics of infections caused by various Nocardia species in Taiwan: a multicenter study from 1998 to 2010. Eur J Clin Microbiol Infect Dis 2011; 30:1341.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/68\" class=\"nounderline abstract_t\">McTaggart LR, Doucet J, Witkowska M, Richardson SE. Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis. Antimicrob Agents Chemother 2015; 59:269.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/69\" class=\"nounderline abstract_t\">Steingrube VA, Brown BA, Gibson JL, et al. DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex. J Clin Microbiol 1995; 33:3096.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/70\" class=\"nounderline abstract_t\">Conville PS, Fischer SH, Cartwright CP, Witebsky FG. Identification of nocardia species by restriction endonuclease analysis of an amplified portion of the 16S rRNA gene. J Clin Microbiol 2000; 38:158.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/71\" class=\"nounderline abstract_t\">Laurent FJ, Provost F, Boiron P. Rapid identification of clinically relevant Nocardia species to genus level by 16S rRNA gene PCR. J Clin Microbiol 1999; 37:99.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/72\" class=\"nounderline abstract_t\">Wilson RW, Steingrube VA, Brown BA, Wallace RJ Jr. Clinical application of PCR-restriction enzyme pattern analysis for rapid identification of aerobic actinomycete isolates. J Clin Microbiol 1998; 36:148.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/73\" class=\"nounderline abstract_t\">McTaggart LR, Richardson SE, Witkowska M, Zhang SX. Phylogeny and identification of Nocardia species on the basis of multilocus sequence analysis. J Clin Microbiol 2010; 48:4525.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/74\" class=\"nounderline abstract_t\">Couble A, Rodr&iacute;guez-Nava V, de Montclos MP, et al. Direct detection of Nocardia spp. in clinical samples by a rapid molecular method. J Clin Microbiol 2005; 43:1921.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/75\" class=\"nounderline abstract_t\">Ooi Y, Shiba H, Nagai K, et al. Lung Nocardia elegans infection diagnosed on matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Intern Med 2014; 53:2111.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/76\" class=\"nounderline abstract_t\">Toyokawa M, Kimura K, Nishi I, et al. Reliable and reproducible method for rapid identification of Nocardia species by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi 2013; 24:1.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/77\" class=\"nounderline abstract_t\">Hsueh PR, Lee TF, Du SH, et al. Bruker biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Nocardia, Rhodococcus, Kocuria, Gordonia, Tsukamurella, and Listeria species. J Clin Microbiol 2014; 52:2371.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/78\" class=\"nounderline abstract_t\">Verroken A, Janssens M, Berhin C, et al. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nocardia species. J Clin Microbiol 2010; 48:4015.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/79\" class=\"nounderline abstract_t\">Blosser SJ, Drake SK, Andrasko JL, et al. Multicenter Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Study for Identification of Clinically Relevant Nocardia spp. J Clin Microbiol 2016; 54:1251.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/80\" class=\"nounderline abstract_t\">Hui CH, Au VW, Rowland K, et al. Pulmonary nocardiosis re-visited: experience of 35 patients at diagnosis. Respir Med 2003; 97:709.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/81\" class=\"nounderline abstract_t\">WEED LA, ANDERSEN HA, GOOD CA, BAGGENSTOSS AH. Nocardiosis; clinical, bacteriologic and pathological aspects. N Engl J Med 1955; 253:1137.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/82\" class=\"nounderline abstract_t\">Jenney AW, McLean CA, Wesselingh SL. Nocardia nova Infection in a HIV-positive Man. Int J STD AIDS 2001; 12:348.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/83\" class=\"nounderline abstract_t\">MURRAY JF, FINEGOLD SM, FROMAN S, WILL DW. The changing spectrum of nocardiosis. A review and presentation of nine cases. Am Rev Respir Dis 1961; 83:315.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/84\" class=\"nounderline abstract_t\">Tilak R, Agarwal D, Lahiri TK, Tilak V. Pulmonary nocardiosis presenting as fungal ball--a rare entity. J Infect Dev Ctries 2008; 2:143.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/85\" class=\"nounderline abstract_t\">Kitamura A, Sakurai T, Tomita K, et al. [A case of primary pulmonary nocardiosis with multiple pulmonary nodules successfully treated with moxifloxacin]. Nihon Kokyuki Gakkai Zasshi 2009; 47:537.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/86\" class=\"nounderline abstract_t\">Wallace RJ Jr, Steele LC, Sumter G, Smith JM. Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother 1988; 32:1776.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/87\" class=\"nounderline abstract_t\">Boiron P, Provost F. In-vitro susceptibility testing of Nocardia spp. and its taxonomic implication. J Antimicrob Chemother 1988; 22:623.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/88\" class=\"nounderline abstract_t\">Wallace RJ Jr, Brown BA, Tsukamura M, et al. Clinical and laboratory features of Nocardia nova. J Clin Microbiol 1991; 29:2407.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/89\" class=\"nounderline abstract_t\">Khardori N, Shawar R, Gupta R, et al. In vitro antimicrobial susceptibilities of Nocardia species. Antimicrob Agents Chemother 1993; 37:882.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/90\" class=\"nounderline abstract_t\">Cercenado E, Mar&iacute;n M, S&aacute;nchez-Mart&iacute;nez M, et al. In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob Agents Chemother 2007; 51:1102.</a></li><li class=\"breakAll\">National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Approved standard. NCCLS document M24-A, National Committee for Clinical Laboratory Standards, Wayne, PA 2003.</li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/92\" class=\"nounderline abstract_t\">Biehle JR, Cavalieri SJ, Saubolle MA, Getsinger LJ. Comparative evaluation of the E test for susceptibility testing of Nocardia species. Diagn Microbiol Infect Dis 1994; 19:101.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-nocardiosis/abstract/93\" class=\"nounderline abstract_t\">Lebeaux D, Freund R, van Delden C, et al. Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study. Clin Infect Dis 2017; 64:1396.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5515 Version 22.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H27\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">RISK FACTORS</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">SITES OF INFECTION</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Pulmonary</a><ul><li><a href=\"#H219372903\" id=\"outline-link-H219372903\">- Imaging findings</a></li></ul></li><li><a href=\"#H5\" id=\"outline-link-H5\">Central nervous system</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Cutaneous</a><ul><li><a href=\"#H7\" id=\"outline-link-H7\">- Primary cutaneous</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">- Lymphocutaneous</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">- Cutaneous manifestations of disseminated nocardiosis</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">- Mycetoma</a></li></ul></li><li><a href=\"#H11\" id=\"outline-link-H11\">Disseminated infection</a><ul><li><a href=\"#H12\" id=\"outline-link-H12\">- Bacteremia</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">- Other sites</a></li></ul></li></ul></li><li><a href=\"#H14\" id=\"outline-link-H14\">DIFFERENTIAL DIAGNOSIS</a><ul><li><a href=\"#H16\" id=\"outline-link-H16\">Pulmonary nocardiosis</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">CNS nocardiosis</a></li><li><a href=\"#H683292219\" id=\"outline-link-H683292219\">Cutaneous nocardiosis</a></li></ul></li><li><a href=\"#H18\" id=\"outline-link-H18\">DIAGNOSIS</a><ul><li><a href=\"#H19\" id=\"outline-link-H19\">Appropriate specimens</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">Gram stain</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">Modified acid-fast staining</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">Culture techniques and incubation</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">Speciation</a></li><li><a href=\"#H19082898\" id=\"outline-link-H19082898\">Histopathology</a></li><li><a href=\"#H25\" id=\"outline-link-H25\">Susceptibility testing</a></li><li><a href=\"#H26\" id=\"outline-link-H26\">Imaging studies</a></li></ul></li><li><a href=\"#H27\" id=\"outline-link-H27\">SUMMARY</a><ul><li><a href=\"#H28\" id=\"outline-link-H28\">Clinical manifestations</a></li><li><a href=\"#H29\" id=\"outline-link-H29\">Diagnosis</a></li></ul></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/5515|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=ID/77089\" class=\"graphic graphic_diagnosticimage\">- Lung nodules in nocardiosis</a></li><li><a href=\"image.htm?imageKey=ID/65316\" class=\"graphic graphic_diagnosticimage\">- Lung infiltrates in nocardiosis</a></li><li><a href=\"image.htm?imageKey=ID/52153\" class=\"graphic graphic_diagnosticimage\">- CNS nocardiosis CT</a></li><li><a href=\"image.htm?imageKey=ID/78604\" class=\"graphic graphic_diagnosticimage\">- Nocardial brain abscess MRI</a></li></ul></li><li><div id=\"ID/5515|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/62568\" class=\"graphic graphic_picture\">- Cutaneous nocardiosis</a></li><li><a href=\"image.htm?imageKey=ID/80426\" class=\"graphic graphic_picture\">- Nocardia on Gram stain</a></li><li><a href=\"image.htm?imageKey=ID/66920\" class=\"graphic graphic_picture\">- Nocardia on modified AFB stain</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-immunocompromised-patient-with-fever-and-pulmonary-infiltrates\" class=\"medical medical_review\">Approach to the immunocompromised patient with fever and pulmonary infiltrates</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bacterial-endophthalmitis\" class=\"medical medical_review\">Bacterial endophthalmitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cellulitis-and-skin-abscess-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Cellulitis and skin abscess: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cerebrospinal-fluid-physiology-and-utility-of-an-examination-in-disease-states\" class=\"medical medical_review\">Cerebrospinal fluid: Physiology and utility of an examination in disease states</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-sporotrichosis\" class=\"medical medical_review\">Clinical features and diagnosis of sporotrichosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=fever-and-rash-in-immunocompromised-patients-without-hiv-infection\" class=\"medical medical_review\">Fever and rash in immunocompromised patients without HIV infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lymphangitis\" class=\"medical medical_review\">Lymphangitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=microbiology-epidemiology-and-pathogenesis-of-nocardiosis\" class=\"medical medical_review\">Microbiology, epidemiology, and pathogenesis of nocardiosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-brain-abscess\" class=\"medical medical_review\">Pathogenesis, clinical manifestations, and diagnosis of brain abscess</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-nocardiosis\" class=\"medical medical_review\">Treatment of nocardiosis</a></li></ul></div></div>","javascript":null}